Role of pharmacists in providing information on cancer genome medicine and patient decision making: Open-label randomized controlled study
Orie Saigo, Shuko Nojiri, Kota Asakura, Shoji Koshiba, Uki Saito, Satoshi Iwakawa, Toshimi Kimura, Shunsuke Kato · 2026
Read Role of pharmacists in providing information on cancer genome medicine and patient decision making: Open-label randomized controlled study by Orie Saigo, Shuko Nojiri, Kota Asakura, Shoji Koshiba, Uki Saito, Satoshi Iwakawa, Toshimi Kimura, Shunsuke Kato (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13325452.txt.
Description
Orie Saigo and colleagues test whether pharmacists can ease decisions about cancer genome testing in a 2026 randomized study in Japan. Genome profiling is routine there, yet patients face hard choices with unfamiliar information.
A total of 180 patients were split between standard medication counseling and added structured teaching about genome profiling. The share whose decision conflict fell did not differ, at 49.4 percent against 41.9 percent for the control group. Still, conflict about treatment choice rose far less in the teaching arm, gaining 1.98 points against 3.61 on the conflict scale. Early pharmacist input thus blunted growing doubt even when final choices matched.
Catalog record
| CREATOR | Orie Saigo, Shuko Nojiri, Kota Asakura, Shoji Koshiba, Uki Saito, Satoshi Iwakawa, Toshimi Kimura, Shunsuke Kato |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47738 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |